A small, yet rapidly growing segment of commercially insured US patients have drug costs of more than $250,000 each year, and this group could account for 15% of all drug expenditures in the next 5 years.
Menu
Study Shows Growth in Number of Drug “Super Spenders”
- Published
- October 18, 2019
- - 4:49 pm
